A single dose of psilocybin combined with psychotherapy produced significant improvements in emotional and existential distress in patients with cancer that lasted more than 4 years, according to a published study.
SAN DIEGO—Signs point to possible approval of MDMA-assisted psychotherapy for post-traumatic stress disorder by late 2021, with Rick Doblin, PhD, telling Psych Congress attendees that this could mark the start of a new field of therapy.
The US Food and Drug Administration (FDA) recently granted Usona Institute, Madison, Wisconsin, the Breakthrough Therapy designation for psilocybin in the treatment of patients with major depressive disorder (MDD).
SAN DIEGO—Psilocybin-assisted psychotherapy appears to have a beneficial and lasting effect on patient mood, but possible approval of the treatment remains some time away, a researcher said at Psych Congress 2019.
SAN FRANCISCO—Alcohol use and cravings decreased in participants with higher scores on the Mystical Experience Questionnaire in a controlled study assessing psilocybin-assisted psychotherapy for alcohol dependence, according to preliminary results presented at the American Psychiatric Association’s annual meeting.
A single dose of the psychedelic drug methylendioxymethamphetamine (MDMA) reopens the critical period for learning the reward value of social behaviors, according to a study published online in Nature.